Jul 11, 2022
SAN FRANCISCO --(BUSINESS WIRE)--Jul. 11, 2022-- Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced the publication of a manuscript
Jun 07, 2022
SAN FRANCISCO --(BUSINESS WIRE)--Jun. 7, 2022-- Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that Frank Karbe will join
Displaying 1 - 10 of 49